Affordable medicines row
the us pharmaceutical industry
Related Content
- Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
- Africa regional strategy on antimicrobial resistance communications and advocacy
- Review of Policies and Strategies for the Pharmaceutical Production Sector in Africa
- Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia
- Drugs of 18 pharma firms found substandard since 2018
- Can people afford to pay for health care: New evidence on financial protection in Europe